Dopamine-inhibited adenylate cyclase in female rat adenohypophysis

Giuliana Giannattasio, Maria Elisabetta De Ferrari, Anna Spada

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

A dopamine-inhibited adenylate cyclase has been demonstrated in anterior pituitary gland of adult female rats, lactating and not lactating. This inhibitory effect was completely GTP dependent. In contrast, in the adenohypophysis of male rats, dopamine had no detectable effect on adenylate cyclase activity. In female rats the inhibition of the enzyme appears mediated by specific dopaminergic receptors: the effect of dopamine was mimicked by the dopaminergic agonists apomorphine and the ergot derivative CH 29-717, while norepinephrine was much less potent. On the other hand, the dopaminergic antagonists trifluoperazine and sulpiride competitively antagonized the dopamine inhibition of the adenylate cyclase. The possibility that the dopamine-inhibited enzyme is located in mammotrophs appears supported 1) by its observation in the female rat pituitary, which contains this type of cells in much larger proportion than the male gland (33-38% vs. <5%); 2) by the pharmacological similarity between the dopaminergic receptors mediating the adenylate cyclase inhibition (this work) and those regulating prolactin release (which have been characterized in previous studies). The well known inhibition of prolactin release brought about by dopamine could therefore be mediated, at least in part, by a decrease in the intracellular level of cAMP.

Original languageEnglish
Pages (from-to)1605-1612
Number of pages8
JournalLife Sciences
Volume28
Issue number14
DOIs
Publication statusPublished - Apr 6 1981

Fingerprint

Anterior Pituitary Gland
Adenylyl Cyclases
Rats
Dopamine
Prolactin
Trifluoperazine
Sulpiride
Dopamine Agents
Dopamine Antagonists
Apomorphine
Dopamine Agonists
Dopamine Receptors
Enzymes
Guanosine Triphosphate
Norepinephrine
Observation
Pharmacology
Derivatives

ASJC Scopus subject areas

  • Pharmacology

Cite this

Dopamine-inhibited adenylate cyclase in female rat adenohypophysis. / Giannattasio, Giuliana; De Ferrari, Maria Elisabetta; Spada, Anna.

In: Life Sciences, Vol. 28, No. 14, 06.04.1981, p. 1605-1612.

Research output: Contribution to journalArticle

Giannattasio, G, De Ferrari, ME & Spada, A 1981, 'Dopamine-inhibited adenylate cyclase in female rat adenohypophysis', Life Sciences, vol. 28, no. 14, pp. 1605-1612. https://doi.org/10.1016/0024-3205(81)90315-5
Giannattasio, Giuliana ; De Ferrari, Maria Elisabetta ; Spada, Anna. / Dopamine-inhibited adenylate cyclase in female rat adenohypophysis. In: Life Sciences. 1981 ; Vol. 28, No. 14. pp. 1605-1612.
@article{3579875a87d34c5c9909f4090ebe8b80,
title = "Dopamine-inhibited adenylate cyclase in female rat adenohypophysis",
abstract = "A dopamine-inhibited adenylate cyclase has been demonstrated in anterior pituitary gland of adult female rats, lactating and not lactating. This inhibitory effect was completely GTP dependent. In contrast, in the adenohypophysis of male rats, dopamine had no detectable effect on adenylate cyclase activity. In female rats the inhibition of the enzyme appears mediated by specific dopaminergic receptors: the effect of dopamine was mimicked by the dopaminergic agonists apomorphine and the ergot derivative CH 29-717, while norepinephrine was much less potent. On the other hand, the dopaminergic antagonists trifluoperazine and sulpiride competitively antagonized the dopamine inhibition of the adenylate cyclase. The possibility that the dopamine-inhibited enzyme is located in mammotrophs appears supported 1) by its observation in the female rat pituitary, which contains this type of cells in much larger proportion than the male gland (33-38{\%} vs. <5{\%}); 2) by the pharmacological similarity between the dopaminergic receptors mediating the adenylate cyclase inhibition (this work) and those regulating prolactin release (which have been characterized in previous studies). The well known inhibition of prolactin release brought about by dopamine could therefore be mediated, at least in part, by a decrease in the intracellular level of cAMP.",
author = "Giuliana Giannattasio and {De Ferrari}, {Maria Elisabetta} and Anna Spada",
year = "1981",
month = "4",
day = "6",
doi = "10.1016/0024-3205(81)90315-5",
language = "English",
volume = "28",
pages = "1605--1612",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "14",

}

TY - JOUR

T1 - Dopamine-inhibited adenylate cyclase in female rat adenohypophysis

AU - Giannattasio, Giuliana

AU - De Ferrari, Maria Elisabetta

AU - Spada, Anna

PY - 1981/4/6

Y1 - 1981/4/6

N2 - A dopamine-inhibited adenylate cyclase has been demonstrated in anterior pituitary gland of adult female rats, lactating and not lactating. This inhibitory effect was completely GTP dependent. In contrast, in the adenohypophysis of male rats, dopamine had no detectable effect on adenylate cyclase activity. In female rats the inhibition of the enzyme appears mediated by specific dopaminergic receptors: the effect of dopamine was mimicked by the dopaminergic agonists apomorphine and the ergot derivative CH 29-717, while norepinephrine was much less potent. On the other hand, the dopaminergic antagonists trifluoperazine and sulpiride competitively antagonized the dopamine inhibition of the adenylate cyclase. The possibility that the dopamine-inhibited enzyme is located in mammotrophs appears supported 1) by its observation in the female rat pituitary, which contains this type of cells in much larger proportion than the male gland (33-38% vs. <5%); 2) by the pharmacological similarity between the dopaminergic receptors mediating the adenylate cyclase inhibition (this work) and those regulating prolactin release (which have been characterized in previous studies). The well known inhibition of prolactin release brought about by dopamine could therefore be mediated, at least in part, by a decrease in the intracellular level of cAMP.

AB - A dopamine-inhibited adenylate cyclase has been demonstrated in anterior pituitary gland of adult female rats, lactating and not lactating. This inhibitory effect was completely GTP dependent. In contrast, in the adenohypophysis of male rats, dopamine had no detectable effect on adenylate cyclase activity. In female rats the inhibition of the enzyme appears mediated by specific dopaminergic receptors: the effect of dopamine was mimicked by the dopaminergic agonists apomorphine and the ergot derivative CH 29-717, while norepinephrine was much less potent. On the other hand, the dopaminergic antagonists trifluoperazine and sulpiride competitively antagonized the dopamine inhibition of the adenylate cyclase. The possibility that the dopamine-inhibited enzyme is located in mammotrophs appears supported 1) by its observation in the female rat pituitary, which contains this type of cells in much larger proportion than the male gland (33-38% vs. <5%); 2) by the pharmacological similarity between the dopaminergic receptors mediating the adenylate cyclase inhibition (this work) and those regulating prolactin release (which have been characterized in previous studies). The well known inhibition of prolactin release brought about by dopamine could therefore be mediated, at least in part, by a decrease in the intracellular level of cAMP.

UR - http://www.scopus.com/inward/record.url?scp=0019830992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019830992&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(81)90315-5

DO - 10.1016/0024-3205(81)90315-5

M3 - Article

C2 - 7242247

AN - SCOPUS:0019830992

VL - 28

SP - 1605

EP - 1612

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 14

ER -